Department of Medicine

October 27, 2016

Trial to test aortic valve technique in lower-risk patients

In 2011, doctors at the Vanderbilt Heart and Vascular Institute performed the state’s first transcatheter valve-replacement (TAVR) procedure for high-risk patients suffering from aortic stenosis, the most common valvular heart disease in the United States.

By Jessica Pasley
Buckwheat seeds on wooden spoon in closeup
October 20, 2016

Study finds natural compound extends lifespan of worms

A compound found in buckwheat seeds extends the lifespan of worms, Vanderbilt investigators have discovered.

By Leigh MacMillan
October 7, 2016

Rheumatoid subtypes explored by PheWAS

A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis.

By Paul Govern
October 6, 2016

Madhur lands NIH New Innovator Award

Meena Madhur, M.D., Ph.D., assistant professor of Medicine, has received an NIH New Innovator Award, which is designed to support exceptionally creative, early-career investigators who propose innovative, high-impact projects.

By Leigh MacMillan
September 29, 2016

BMI genotype and breast cancer risk

For breast cancer prevention, a new study provides evidence for lifestyle modification to reduce weight gain in adults.

By Paul Govern
white pills spilling out of a prescription bottle
September 22, 2016

‘Shed-Meds’ to explore helping elderly reduce number of medications

Vanderbilt University Medical (VUMC) researchers have received a $2.9 million federal grant to test the effectiveness of a new intervention that aims to help older patients reduce the number of medications they may be taking on a regular basis.

By Kristin Smart
September 22, 2016

H. pylori and anemia – new evidence

The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide.
By Bill Snyder
September 15, 2016

Study explores anti-viral potential of existing drugs

Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market.
By Bill Snyder
September 8, 2016

Going after the ‘heart attack gremlin’

A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target.
By Sanjay Mishra
August 30, 2016

VUMC mourns loss of Nephrology’s Schulman

Gerald Schulman, M.D., professor of Medicine, died Aug. 26. He was 65.
By Kathy Whitney
August 29, 2016

Nervous system’s role in hypertension

Increased activity of the “fight or flight” nervous system contributes to obesity-associated hypertension and may be a good therapeutic target for the disease.
By Leigh MacMillan
June 23, 2016

It takes two to tango: beta cell development

Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes.
By Bill Snyder
June 9, 2016

Landmark report urges caution before releasing gene drive-modified organisms

A new report released this week raises questions about “gene drives,” a biological process that can profoundly and rapidly alter the characteristics of entire species.
By Bill Snyder
1 … 68 69 70 71 72 … 86